Treatment of Hodgkin's disease: A twenty-year follow-up of patients at a center in Korea

June Won Cheong, Soo Young Park, Jae Kyung Roh, Chang Ok Suh, Jee Sook Hahn

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Hodgkin's disease (HD) is a hematologic malignancy which shows common features regardless of race, but racial differences may be considered with certain clinical characteritcs. HD in Korea shows somewhat different characteristics when compared to cases in Western countries. We evaluated the clinical and histopathologic characteristics of HD, the outcomes of various chemotherapy regimens, and prognostic factors of HD in Korea. One hundred and five patients with initial histopathologic diagnosis of Hodgkin's disease were retrospectively reviewed 20 years after diagnosis at Yonsei University College of Medicine. Nodular sclerosis was the most common histopathogic subtype (41%) and mixed cellularity was nearly as common (40%). The overall complete remission rate (CR) was 87.6%. The disease-free survival (DFS) and overall survival (OS) rate were 79.2% and 84.8% at 5-years, 70% and 79.2% at 10- and 20-years. There were no significant differences in CR rate and DFS, but OS rates were significantly higher in m-BACOP and ABVD regimen. Univariate analysis revealed that age, B-symptom, ECOG scale, Ann Arbor stage, international prognostic index, and serum β2-microglobulin level were significant prognostic factors for both DFS and OS. Multivariate analysis demonstrated that age, B symptoms, and ECOG scale were significant prognostic factors for OS only. In conclusion, the survival rates of HD patients in our center were superior to those of previous reports in Korea and Western countries. Considering the higher OS rate and decreased incidence of side effects, the ABVD regimen may be recommended for the initial treatment of Hodgkin's disease.

Original languageEnglish
Pages (from-to)455-465
Number of pages11
JournalYonsei medical journal
Volume47
Issue number4
DOIs
Publication statusPublished - 2006 Aug

Fingerprint

Korea
Hodgkin Disease
Survival Rate
Disease-Free Survival
Therapeutics
Survival
Sclerosis
Hematologic Neoplasms
Multivariate Analysis
Medicine
Drug Therapy
Incidence
Serum

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Cheong, June Won ; Park, Soo Young ; Roh, Jae Kyung ; Suh, Chang Ok ; Hahn, Jee Sook. / Treatment of Hodgkin's disease : A twenty-year follow-up of patients at a center in Korea. In: Yonsei medical journal. 2006 ; Vol. 47, No. 4. pp. 455-465.
@article{8d60ff241b7f427c800425929a2d0331,
title = "Treatment of Hodgkin's disease: A twenty-year follow-up of patients at a center in Korea",
abstract = "Hodgkin's disease (HD) is a hematologic malignancy which shows common features regardless of race, but racial differences may be considered with certain clinical characteritcs. HD in Korea shows somewhat different characteristics when compared to cases in Western countries. We evaluated the clinical and histopathologic characteristics of HD, the outcomes of various chemotherapy regimens, and prognostic factors of HD in Korea. One hundred and five patients with initial histopathologic diagnosis of Hodgkin's disease were retrospectively reviewed 20 years after diagnosis at Yonsei University College of Medicine. Nodular sclerosis was the most common histopathogic subtype (41{\%}) and mixed cellularity was nearly as common (40{\%}). The overall complete remission rate (CR) was 87.6{\%}. The disease-free survival (DFS) and overall survival (OS) rate were 79.2{\%} and 84.8{\%} at 5-years, 70{\%} and 79.2{\%} at 10- and 20-years. There were no significant differences in CR rate and DFS, but OS rates were significantly higher in m-BACOP and ABVD regimen. Univariate analysis revealed that age, B-symptom, ECOG scale, Ann Arbor stage, international prognostic index, and serum β2-microglobulin level were significant prognostic factors for both DFS and OS. Multivariate analysis demonstrated that age, B symptoms, and ECOG scale were significant prognostic factors for OS only. In conclusion, the survival rates of HD patients in our center were superior to those of previous reports in Korea and Western countries. Considering the higher OS rate and decreased incidence of side effects, the ABVD regimen may be recommended for the initial treatment of Hodgkin's disease.",
author = "Cheong, {June Won} and Park, {Soo Young} and Roh, {Jae Kyung} and Suh, {Chang Ok} and Hahn, {Jee Sook}",
year = "2006",
month = "8",
doi = "10.3349/ymj.2006.47.4.455",
language = "English",
volume = "47",
pages = "455--465",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "4",

}

Treatment of Hodgkin's disease : A twenty-year follow-up of patients at a center in Korea. / Cheong, June Won; Park, Soo Young; Roh, Jae Kyung; Suh, Chang Ok; Hahn, Jee Sook.

In: Yonsei medical journal, Vol. 47, No. 4, 08.2006, p. 455-465.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Treatment of Hodgkin's disease

T2 - A twenty-year follow-up of patients at a center in Korea

AU - Cheong, June Won

AU - Park, Soo Young

AU - Roh, Jae Kyung

AU - Suh, Chang Ok

AU - Hahn, Jee Sook

PY - 2006/8

Y1 - 2006/8

N2 - Hodgkin's disease (HD) is a hematologic malignancy which shows common features regardless of race, but racial differences may be considered with certain clinical characteritcs. HD in Korea shows somewhat different characteristics when compared to cases in Western countries. We evaluated the clinical and histopathologic characteristics of HD, the outcomes of various chemotherapy regimens, and prognostic factors of HD in Korea. One hundred and five patients with initial histopathologic diagnosis of Hodgkin's disease were retrospectively reviewed 20 years after diagnosis at Yonsei University College of Medicine. Nodular sclerosis was the most common histopathogic subtype (41%) and mixed cellularity was nearly as common (40%). The overall complete remission rate (CR) was 87.6%. The disease-free survival (DFS) and overall survival (OS) rate were 79.2% and 84.8% at 5-years, 70% and 79.2% at 10- and 20-years. There were no significant differences in CR rate and DFS, but OS rates were significantly higher in m-BACOP and ABVD regimen. Univariate analysis revealed that age, B-symptom, ECOG scale, Ann Arbor stage, international prognostic index, and serum β2-microglobulin level were significant prognostic factors for both DFS and OS. Multivariate analysis demonstrated that age, B symptoms, and ECOG scale were significant prognostic factors for OS only. In conclusion, the survival rates of HD patients in our center were superior to those of previous reports in Korea and Western countries. Considering the higher OS rate and decreased incidence of side effects, the ABVD regimen may be recommended for the initial treatment of Hodgkin's disease.

AB - Hodgkin's disease (HD) is a hematologic malignancy which shows common features regardless of race, but racial differences may be considered with certain clinical characteritcs. HD in Korea shows somewhat different characteristics when compared to cases in Western countries. We evaluated the clinical and histopathologic characteristics of HD, the outcomes of various chemotherapy regimens, and prognostic factors of HD in Korea. One hundred and five patients with initial histopathologic diagnosis of Hodgkin's disease were retrospectively reviewed 20 years after diagnosis at Yonsei University College of Medicine. Nodular sclerosis was the most common histopathogic subtype (41%) and mixed cellularity was nearly as common (40%). The overall complete remission rate (CR) was 87.6%. The disease-free survival (DFS) and overall survival (OS) rate were 79.2% and 84.8% at 5-years, 70% and 79.2% at 10- and 20-years. There were no significant differences in CR rate and DFS, but OS rates were significantly higher in m-BACOP and ABVD regimen. Univariate analysis revealed that age, B-symptom, ECOG scale, Ann Arbor stage, international prognostic index, and serum β2-microglobulin level were significant prognostic factors for both DFS and OS. Multivariate analysis demonstrated that age, B symptoms, and ECOG scale were significant prognostic factors for OS only. In conclusion, the survival rates of HD patients in our center were superior to those of previous reports in Korea and Western countries. Considering the higher OS rate and decreased incidence of side effects, the ABVD regimen may be recommended for the initial treatment of Hodgkin's disease.

UR - http://www.scopus.com/inward/record.url?scp=33748325786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748325786&partnerID=8YFLogxK

U2 - 10.3349/ymj.2006.47.4.455

DO - 10.3349/ymj.2006.47.4.455

M3 - Review article

C2 - 16941733

AN - SCOPUS:33748325786

VL - 47

SP - 455

EP - 465

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 4

ER -